APO MYC500 (Mycophenolate Mofetil 500 mg)
Pill with imprint APO MYC500 is Purple, Capsule-shape and has been identified as Mycophenolate Mofetil 500 mg. It is supplied by Apotex Corp.
Mycophenolate mofetil is used in the treatment of nephrotic syndrome; organ transplant, rejection prophylaxis; graft-versus-host disease and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO MYC500
- APO MYC500
- 500 mg
- 16.00 mm
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Apotex Corp.
- Inactive Ingredients
ferric oxide red,
Note: Inactive ingredients may vary.
Labelers / Repackagers
|NDC Code||Labeler / Repackager|
|60505-2967 (Discontinued)||Apotex Corp.|
|68084-0588 (Discontinued)||Amerisource Health Services|
More about mycophenolate mofetil
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (53)
- Drug images
- Pricing & coupons
- En español
- Drug class: selective immunosuppressants
- Drug Information
- Mycophenolate Intravenous (Advanced Reading)
- Mycophenolate mofetil (Advanced Reading)
- Mycophenolate Mofetil Capsules
- Mycophenolate Mofetil Tablets
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.